GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Cyclically Adjusted Revenue per Share

Bayer AG (Bayer AG) Cyclically Adjusted Revenue per Share : $14.92 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Bayer AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer AG's adjusted revenue per share for the three months ended in Dec. 2023 was $3.292. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $14.92 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Bayer AG's average Cyclically Adjusted Revenue Growth Rate was 1.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer AG was 3.90% per year. The lowest was 0.30% per year. And the median was 2.10% per year.

As of today (2024-04-27), Bayer AG's current stock price is $7.39. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $14.92. Bayer AG's Cyclically Adjusted PS Ratio of today is 0.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 3.18. The lowest was 0.48. And the median was 1.53.


Bayer AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Revenue per Share Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.71 14.95 14.15 14.27 14.92

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.27 14.90 14.95 14.49 14.92

Competitive Comparison of Bayer AG's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.



Bayer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.292/123.6675*123.6675
=3.292

Current CPI (Dec. 2023) = 123.6675.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 4.411 99.543 5.480
201406 4.192 99.543 5.208
201409 3.887 99.823 4.816
201412 4.029 99.543 5.005
201503 3.903 99.717 4.840
201506 4.051 100.417 4.989
201509 3.740 100.417 4.606
201512 3.713 99.717 4.605
201603 3.991 100.017 4.935
201606 4.019 100.717 4.935
201609 2.802 101.017 3.430
201612 2.740 101.217 3.348
201703 2.970 101.417 3.622
201706 2.765 102.117 3.349
201709 2.700 102.717 3.251
201712 2.872 102.617 3.461
201803 3.181 102.917 3.822
201806 3.024 104.017 3.595
201809 2.756 104.718 3.255
201812 3.003 104.217 3.563
201903 3.531 104.217 4.190
201906 3.083 105.718 3.606
201909 2.755 106.018 3.214
201912 3.040 105.818 3.553
202003 3.612 105.718 4.225
202006 2.881 106.618 3.342
202009 2.550 105.818 2.980
202012 3.094 105.518 3.626
202103 3.735 107.518 4.296
202106 3.328 108.486 3.794
202109 2.928 109.435 3.309
202112 3.197 110.384 3.582
202203 4.103 113.968 4.452
202206 3.448 115.760 3.684
202209 2.842 118.818 2.958
202212 3.235 119.345 3.352
202303 3.920 122.402 3.961
202306 3.045 123.140 3.058
202309 2.809 124.195 2.797
202312 3.292 123.668 3.292

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bayer AG  (OTCPK:BAYRY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.39/14.92
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 3.18. The lowest was 0.48. And the median was 1.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Cyclically Adjusted Revenue per Share
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.